decisionhealth Newsletters, Answer Books - 2006 Issue 3 (March)
Program_Memos / 2000 / AB-00-21
Subscribe or sign in to view the full article.
Article Overview
This memorandum explains a Medicare program policy update concerning coverage of self-administered injectable drugs and biologicals. It is relevant to Medicare intermediaries and carriers, and it summarizes the administrative context, effective and implementation dates, and the guidance sources referenced for local policy development.
Why This Topic Matters
The article helps Medicare billing and coverage stakeholders understand an interim policy change and how it affects carrier and intermediary handling of injectable drug and biological coverage guidance.
What You Will Learn
- The administrative purpose of the memorandum
- Which Medicare stakeholders are addressed
- The policy context and timing of the update
- What prior guidance sources are referenced for coverage policy development
Who Should Read This
- Medicare carriers
- Medicare intermediaries
- Health care reimbursement professionals
- Medical coding and billing staff
- Compliance and reimbursement teams
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com